TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +1.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow XLO
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +343.8% +40.8% +23.2% +2.9% -13.5% -6.3%
– +1,057.1% +282.6% +69.9% -12.4% -12.8% +7.8%
– – +252.5% +67.9% – – –
– +1,983.1% -171.1% – -182.7% – -20.9%
– +206.0% -49.7% +69.7% -74.0% -92.6% +1,338.9%
– +206.0% -49.7% +69.7% -74.0% -92.6% +1,338.9%
– – – -100.0% +1,112.5% – –
– -101.0% -74.7% +240.0% +7,843.5% -49.9% -100.0%
– -83.3% +2,499.1% -100.0% +9,392.8% – +200.6%
– -168.1% – -143.4% – – +663.0%
– – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?